Lyell Immunopharma is a biotechnology company focused on developing next-generation cell therapies for cancer. Its work centers on technologies intended to improve the durability and effectiveness of T-cell therapies.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!